Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Three's company

How the serotonin component of Neurovance's ADHD candidate could set it apart

February 2, 2015 8:00 AM UTC

Stimulants are the most effective drugs for ADHD, but the very things that make them effective - blocking norepinephrine and dopamine reuptake - can also lead to addiction and cause anxiety. Neurovance Inc.'s lead candidate for ADHD acts on two of the same neurotransmitters as stimulants, but adds serotonin, which could act as an abuse deterrent without sacrificing efficacy.

Low levels of dopamine and norepinephrine cause problems with cognition and focus. Stimulants inhibit transporter proteins responsible for clearing these neurotransmitters, thereby increasing their concentration in the prefrontal cortex. However, increased levels of norepinephrine also cause anxiety, and because higher levels of dopamine also trigger a reward/pleasure feeling, it can cause addiction. Non-stimulants do not have those liabilities, but the trade-off is a drop in efficacy. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article